Position in INCY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,285,904
-$7,393,585 QoQ
Shares Held
20,165
-80.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#314
of 849 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BURNEY CO/ holds $24,564,619 across 12 Biotechnology names. INCY ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
22,078 | $5,320,135 | |
| 2 | EXEL |
Exelixis, Inc.
|
56,478 | $3,072,967 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
37,320 | $3,044,192 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
42,252 | $2,400,336 | |
| 5 | INCY |
Incyte Corp
This page
|
20,165 | $2,285,904 | |
| 6 | RIGL |
Rigel Pharmaceuticals Inc
|
55,769 | $2,181,683 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
24,156 | $2,100,363 | |
| 8 | ANAB |
Anaptysbio, Inc
|
22,557 | $1,522,597 |
All Filings in INCY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,285,904 | 20,165 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $9,679,489 | 102,842 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,920,431 | 29,568 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,882,782 | 22,200 | Shares | Sole | 2025-10-16 | |
| 2024-12-31 | $225,306 | 3,262 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $200,877 | 3,039 | Shares | Sole | 2024-10-18 | |
| 2022-09-30 | $1,344,528 | 20,176 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||